Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 23:12:779620.
doi: 10.3389/fmicb.2021.779620. eCollection 2021.

Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury

Affiliations
Review

Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury

Xin Zhou et al. Front Microbiol. .

Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are common acute and severe cases of the respiratory system with complicated pathogenesis and high mortality. Sepsis is the leading indirect cause of ALI/ARDS in the intensive care unit (ICU). The pathogenesis of septic ALI/ARDS is complex and multifactorial. In the development of sepsis, the disruption of the intestinal barrier function, the alteration of gut microbiota, and the translocation of the intestinal microbiome can lead to systemic and local inflammatory responses, which further alter the immune homeostasis in the systemic environment. Disruption of homeostasis may promote and propagate septic ALI/ARDS. In turn, when ALI occurs, elevated levels of inflammatory cytokines and the shift of the lung microbiome may lead to the dysregulation of the intestinal microbiome and the disruption of the intestinal mucosal barrier. Thus, the interaction between the lung and the gut can initiate and potentiate sepsis-induced ALI/ARDS. The gut-lung crosstalk may be a promising potential target for intervention. This article reviews the underlying mechanism of gut-lung crosstalk in septic ALI/ARDS.

Keywords: acute lung injury; gut microbiome; gut-lung crosstalk; inflammation; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Effect of increased inflammatory cytokines and lung microbiome alteration on the gut in septic ALI/ARDS.
FIGURE 2
FIGURE 2
Intestinal barrier disruption by increased cytokines during sepsis. Tight junctions between cells play a critical role in gut barrier function. In sepsis, tight junctions are destructed by inflammatory cytokines production.
FIGURE 3
FIGURE 3
Effect of sepsis-related intestinal failure on the lung. Bacterial dysbiosis can activate local intestinal inflammatory responses, producing DAMPs, which enter the systemic circulation through mesenteric lymphatic vessels. Immune cells recognize DAMPs and secreting pro-inflammatory factors that promote lung injury. DAMPs: danger-associated molecular patterns.

References

    1. Abe T., Madotto F., Pham T., Nagata I., Uchida M., Tamiya N., et al. (2018). Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries. Crit. Care 22:195. 10.1186/s13054-018-2126-6 - DOI - PMC - PubMed
    1. Adelman M. W., Woodworth M. H., Langelier C., Busch L. M., Kempker J. A., Kraft C. S., et al. (2020). The gut microbiome’s role in the development, maintenance, and outcomes of sepsis. Crit. Care 24:278. 10.1186/s13054-020-02989-1 - DOI - PMC - PubMed
    1. Agudelo-Ochoa G. M., Valdés-Duque B. E., Giraldo-Giraldo N. A., Jaillier-Ramírez A. M., Giraldo-Villa A., Acevedo-Castaño I., et al. (2020). Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes 12:1707610. 10.1080/19490976.2019.1707610 - DOI - PMC - PubMed
    1. Alverdy J. C., Krezalek M. A. (2017). Collapse of the microbiome, emergence of the pathobiome, and the immunopathology of sepsis. Crit. Care Med. 45 337–347. 10.1097/CCM.0000000000002172 - DOI - PMC - PubMed
    1. Assimakopoulos S. F., Triantos C., Thomopoulos K., Fligou F., Maroulis I., Marangos M., et al. (2018). Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection 46 751–760. 10.1007/s15010-018-1178-5 - DOI - PubMed

LinkOut - more resources